Jacob Graham is a partner in the Life Sciences practice at Guidehouse.

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.

Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis is accelerating investor interest, validating biomarker-driven ADCs, and shaping distinct strategic ...

Unlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership ...

Global leader in mother and childcare, Philips Avent, announced a partnership with March of Dimes to establish the modern-day ...

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.

Paul Sullivan is Associate Director, Business Development at Noble International Inc., a developer of patient-centric advanced drug delivery system trainers including autoinjector, prefilled syringe, ...